Bioimmunate ^{For Profit}

BIOIMMUNATE TECHNOLOGIES Ltd. is a company that develops personalized medical platforms to treat autoimmune diseases. They focus on creating precise medicine technology of blood filtration to autoimmune diseases based on the removal of harmful cells from the human body. The company's current research and development are focused on multiple sclerosis (MS) patients. Their goal is to replace the MS pharmaceutical treatments that are accompanied by toxic side effects with a non-pharmacological treatment. They have developed a unique biological cell removal filter that is able to recognize, capture, and remove targeted cells from the blood before they reach the brain. The company's value proposition includes a considerable improvement of patient life expectancy and quality of life, safe procedure, and reduced healthcare and reimbursement costs. The company is backed by internationally renowned Key Opinion Leaders who are members of the Company’s Scientific Advisory Board. Contact_info: N/A.